| Literature DB >> 15827200 |
Jayati Mullick1, Akhilesh K Singh, Yogesh Panse, Vivekanand Yadav, John Bernet, Arvind Sahu.
Abstract
Recently it has been shown that kaposica, an immune evasion protein of Kaposi's sarcoma-associated herpesvirus, inactivates complement by acting on C3-convertases by accelerating their decay as well as by acting as a cofactor in factor I-mediated inactivation of their subunits C3b and C4b. Here, we have mapped the functional domains of kaposica. We show that SCRs 1 and 2 (SCRs 1-2) and 1-4 are essential for the classical and alternative pathway C3-convertase decay-accelerating activity (DAA), respectively, while the SCRs 2-3 are required for factor I cofactor activity (CFA) for C3b and C4b. SCR 3 and SCRs 1 and 4, however, contribute to optimal classical pathway DAA and C3b CFA, respectively. Binding data show that SCRs 1-4 and SCRs 1-2 are the smallest structural units required for measuring detectable binding to C3b and C4b, respectively. The heparin-binding site maps to SCR 1.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15827200 PMCID: PMC1082731 DOI: 10.1128/JVI.79.9.5850-5856.2005
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103